Earnings 8 min read

Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?

Published:
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?

Consumer staples were supposed to be the quiet corner of the market in 2026. Coca-Cola (KO) skipped that part. The stock closed 2025 at $69.91 and traded around $92.81 on October 21. That’s a gain of ~33% this year, and it hit a new 52-week high in mid-October. It’s a big move for a company guiding to ~5% organic growth.

That makes the Q3 2026 report, due before the market opens on October 27 (company announcement), more important than a typical Coke quarter. My view: the business is executing well, but the stock trades at ~28x the midpoint of this year’s EPS guidance. At that price, management needs to show its second-half outlook is conservative, not just reachable.

Two raises, and a cushion built in

On July 28, Coca-Cola raised its full-year outlook for the second time in 2026 (Q2 2026 earnings release, Exhibit 99.1):

  • Organic revenue (sales growth excluding currency and acquisitions/divestitures): ~5%, up from 4% to 5%.
  • Comparable EPS (adjusted, non-GAAP): 9% to 10% growth vs. $3.00 in 2025, up from 8% to 9%. This includes a ~3% currency tailwind and a ~1% drag from acquisitions/divestitures.
  • Comparable currency-neutral EPS, excluding acquisitions/divestitures: 7% to 8%, up from 6% to 7%.
  • Free cash flow: ~$12.4 billion, up from ~$12.2 billion, with capex steady at ~$2.2 billion.

The trend says a lot. February’s first guide called for 7% to 8% comparable EPS growth (Q4 2025 release). April lifted it to 8% to 9% (Q1 2026 release), and July raised it again. Management clearly guides with room to spare.

Q2 earned the July raise. Net revenues rose 7% y/y to $13.38 billion and organic revenue grew 6%. Unit case volume (what bottlers sell to retailers, measured in cases) rose 5%, and comparable EPS rose 11% to $0.97. Comparable operating margin widened ~90 bps to 35.6%.

For Q3 specifically, CFO John Murphy said on the Q2 call that concentrate shipments should “lag unit case volume by 1 point during the third quarter.” The release also points to a ~1% currency tailwind and a ~1% acquisition/divestiture headwind on Q3 comparable net revenue, plus a ~3% currency lift to comparable EPS.

The math points to a sharp slowdown

This is the setup for the quarter. Comparable EPS was $0.86 in Q1 and $0.97 in Q2, so the first half came to $1.83. That’s up ~14% from $1.60 a year earlier. The full-year guide works out to $3.27 to $3.30, which leaves $1.44 to $1.47 for the second half. Against the $1.40 Coke earned in H2 2025, that’s growth of only ~3% to 5% (my math, from the reported quarterly figures).

That’s a steep drop from 14%. Part of it is real: Q4 2026 has six fewer days than Q4 2025 because of a calendar shift. CEO Henrique Braun said on the call that the company is “cycling a higher comp and six less days, but the momentum continues to be there.”

Still, Q3 doesn’t carry the calendar problem. That makes it the cleanest test of whether the second-half slowdown is a quirk of the math or a real loss of demand.

What I expect on October 27

Last year’s Q3 is an unusual comparison. Organic revenue grew 6% in Q3 2025, and all of that growth came from price/mix (+6%). Unit case volume rose just 1% and concentrate sales were flat. Comparable EPS was $0.82 (Q3 2025 release). So this year’s volume comparison is easy, and the pricing comparison is hard.

Braun said in July that 2026 would be a year of volume and price/mix “coming more in tandem.” Q2 showed what that looks like: price/mix rose 2% (3 points of pricing, minus 1 point of mix) while volume grew 5%. I expect Q3 to look similar, with organic growth around mid-single digits but built more on volume than last year’s pricing-led quarter.

On earnings, the ~3% currency tailwind alone would lift last year’s $0.82 to ~$0.84. I’d want comparable EPS clearly above that. A quarter that grows only through currency would suggest the cautious second-half guide is accurate after all.

Unit case volume vs. concentrate sales is the first number I’ll check. A gap much wider than the guided 1 point would raise questions about bottler inventory. Next is price/mix: positive but modest is fine, while mix much worse than −1 point would signal trading down. Then I’ll look at comparable operating margin against 31.9% a year ago. Last, the guide: a third raise would be a strong signal, while a simple reaffirmation could disappoint at this valuation.

What’s changed since July

North America leadership. Jennifer Mann stepped down as head of the North America operating unit on July 31, and Murphy has run it on an interim basis since August 1 (8-K, June 2026). On September 25, Coke named Rob Gehring to the role, effective December 1 (announcement). Gehring was most recently Monster Energy’s CEO, Americas, and previously ran Swire Coca-Cola USA. North America grew comparable currency-neutral operating income 12% in Q2, so having the CFO also run that region for four months is worth a question.

Africa refranchising. Coke agreed in October 2025 to sell a controlling stake in Coca-Cola Beverages Africa to Coca-Cola HBC (announcement). The deal reportedly won conditional approval from South Africa’s Competition Tribunal in September (report). The Q2 10-Q expected closing by the end of 2026, and Murphy said he expects Q4 gross and operating margins to benefit. Selling a low-margin bottling business makes Coke’s margins look better on paper, so I’ll want a clear split between that structural lift and true operating improvement.

fairlife. A ransomware attack briefly stopped production at the dairy brand in July. Coke said output had largely resumed at its four U.S. plants and that the incident isn’t reasonably likely to have a material impact (update). Murphy said there was no impact on Q2 results.

Dividend. The board declared another $0.53 quarterly dividend in October (release). That’s a ~2.3% yield at today’s price, well below what income buyers got when the stock was near $70.

Ranked risks, and one upside lever

1. Valuation (the biggest risk). At ~28x the $3.285 guidance midpoint, KO is priced for steady upside surprises. That’s a rich multiple for high-single-digit EPS growth. Even a solid beat could already be in the price.

2. The low-income consumer. Braun was direct: “the lower income continues to be pressured. And we’re seeing that it’s really about value, not only pricing.” He also called Mexico a difficult environment and said sentiment in China “remains cautious.” The early warning signs would be weaker mix and slowing Latin America volume.

3. The IRS tax case. Murphy said “the timing of a decision from the appellate court is unknown at this stage.” The guided tax rate excludes any litigation impact. This won’t show up in Q3 numbers, but a ruling could reset the cash-return story.

Upside lever: help below the operating line. Murphy said the guide reflects “some benefits on below the line.” If those items and currency hold up, there’s room for a fourth raise in February even if volume cools.

Three things management should explain

The first is EMEA. Braun said profit there fell in Q2 “due to the phasing of investment,” and comparable currency-neutral operating income dropped 5%. If that was really just timing, Q3 should show a rebound.

The second is how much of Q2 was one-off. Braun credited the FIFA World Cup with helping Trademark Coca-Cola volume grow 5%, but said “it’s difficult to quantify.” Q3 is the first quarter after that boost, so volume holding near Q2’s pace would be the best evidence the momentum is real.

Before making your next move, analyze the stock in detail. See what the fundamentals suggest, where momentum is building or weakening, how the company compares against competitors, and whether insiders are buying or selling into the current trend into a single report in seconds.

The third is Q4 itself. Murphy has flagged the six fewer days, but not their dollar impact. A number would help investors judge how conservative the guide really is.

The quarter has to justify the multiple

Coke’s business isn’t the question. The brand is gaining volume again, margins are widening and free cash flow guidance keeps moving up. The question is whether a ~33% rally has already priced all of that in.

I’d turn more optimistic if Q3 shows mid-single-digit volume growth, positive price/mix, margin expansion and a third guidance raise. I’d turn more cautious if volume slides back toward low single digits without the World Cup and the guide is only reaffirmed. On Tuesday, look at unit case volume before the EPS line: that number will show whether this rally has more room.

Vishal Jadaun

Latest analysis

Share This Insight

Disclaimer & Disclosure Tickzen Research is a financial analysis platform. All content, tools, metrics, and models provided in this article are for informational and educational purposes only and should not be construed as investment, financial, legal, or tax advice. Financial markets involve substantial risk of loss. Past performance does not guarantee future results. Consult a licensed financial professional prior to making any investment decision. Review our Editorial Policy and analysis methodology.
Tickzen Insights Catalog

Looking for More Stock Theses & Valuation Breakdowns?

Browse our complete research library for DCF fair-value estimates, earnings recaps, and fundamental stock audits.

Return to All Insights

Discussion & Perspectives

Join the conversation and share your valuation thesis or technical insights.

Comments

Sign in to join the discussion

Only verified Tickzen members can publish comments and share research perspectives.

Log In to Comment
  • Loading comments…